New FY 2020 NIDDK Award Funding Policy Includes Improved Paylines

By Ryan Murray

February 18, 2020

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) posted its award funding policy for fiscal year (FY) 2020, including released paylines that are better than previous years.

NIDDK is establishing a nominal payline for new (Type 1) and renewal or competing continuation (Type 2) R01 applications of 16th percentile in FY 2020, which is higher than the 13th percentile in FY 2019.

niddk.PNGIn addition, NIDDK announced establishing a nominal payline for R01 applications submitted by early stage investigators (ESIs) at the 25th percentile for FY 2020. ESIs are defined as new investigators within 10-years of their terminal research degree or medical residency who have not yet been awarded a substantial, competing NIH research grant. The ESI payline is up from the 18th percentile in FY 2019.

The rise in paylines follows an increase in appropriations with NIDDK receiving $2.11 billion in FY 2020, a 4.1% increase over its FY 2019 appropriation levels. The increase is the result of a sustained advocacy effort in support of NIDDK funding by the American Society of Nephrology and the broader kidney community.
 

Category:
Subcategory:
Author:
Ryan Murray
Body:

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) posted its award funding policy for fiscal year (FY) 2020, including released paylines that are better than previous years.

NIDDK is establishing a nominal payline for new (Type 1) and renewal or competing continuation (Type 2) R01 applications of 16th percentile in FY 2020, which is higher than the 13th percentile in FY 2019.

niddk.PNGIn addition, NIDDK announced establishing a nominal payline for R01 applications submitted by early stage investigators (ESIs) at the 25th percentile for FY 2020. ESIs are defined as new investigators within 10-years of their terminal research degree or medical residency who have not yet been awarded a substantial, competing NIH research grant. The ESI payline is up from the 18th percentile in FY 2019.

The rise in paylines follows an increase in appropriations with NIDDK receiving $2.11 billion in FY 2020, a 4.1% increase over its FY 2019 appropriation levels. The increase is the result of a sustained advocacy effort in support of NIDDK funding by the American Society of Nephrology and the broader kidney community.
 

Date:
Tuesday, February 18, 2020